Elaine Levitt

IVAX LLC discovers, develops, manufactures, and markets generic pharmaceuticals, respiratory drugs, and cancer treatments. It offers drugs for the treatment of multiple sclerosis, brain cancer, asthma, and epilepsy. The company was founded by Phillip Frost and Jane H. Hsiao in 1985 and is headquartered in Weston, FL.

RAE Systems, Inc. provides intelligent gas and radiation detection systems. It offers wireless enabled solutions including personal, hand-held, transportable, and fixed instruments. The firm's products include MultiRAE, QRAE 3 and AutoRAE 2. The company was founded by Robert I. Chen and Peter C. Hsi in 1991 and is headquartered in San Jose, CA.

The Cue Ball Group LLC (Cue Ball capital) is a venture Capital firm founded in 2005 by Tjan Anthony K and Hamel John Daniele. The firm is headquartered in Boston, Massachusetts.

Kirax Corp. researches, develops, manufactures and distributes pharmaceutical products. The firm provides specialty care therapies to treat oncology, pain, inflammation, acute, and supportive care areas of unmet medical need. The company was founded by Mark E. Pruzanski, David M. Tanen and Edmundo Muniz in 2005 and is headquartered in Bonita Springs, FL.

Cantex Pharmaceuticals, Inc. develops heparin to ameliorate cardiac ischemia-reperfusion injuries. It also develops medications to enhance the safety and effectiveness of existing cancer treatments. The firm provides Disulfiram + copper Chelate that includes non-overlapping cancer stem cell killing mechanisms of actions. The company was founded in 2013 by Thomas P. Kennedy, Neil William Flanzraich and Stephen G. Marcus and is headquartered in Weston, FL.

Javelin Pharmaceuticals, Inc. develops pharmaceutical drugs. It is a specialty pharmaceutical company that applies innovative proprietary technologies to develop new drugs and improved formulations of existing drugs that target current unmet and underserved medical market. The company's product candidates address the acute moderate-to-severe pain medication market segment. It has three late stage product candidates in development: Dyloject (diclofenac sodium, injectable), Rylomine (intranasal morphine) and PMI-150 (intranasal ketamine). The company was founded on February 23, 1998 and is headquartered in Cambridge, MA.

Neurochem (International) Ltd. provides licensing and partnering activities. Its services include supply chain management and sales, clinical, and regulatory & marketing functions required to develop products. Neurochem is headquartered in Lausanne, Switzerland.

Part of Roche Bay Plc, Syntex (USA), Inc. is a company that manufactures and wholesales pharmaceutical products. The company is based in Palo Alto, CA.

AgoneX Biopharmaceuticals Inc. engages in the development and commercialization of therapeutics for migraine headaches. The company was founded by Cris Arnou and Neil William Flanzraich and is headquartered in Santa Monica, CA.